Home LiteratureArticle Details
PMID: 12517468 Published · ppublish English Clinical Trial Journal Article Research Support, Non-U.S. Gov't

Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation.

Lancet (London, England) ·Vol. 361 ·No. 9351 ·2003-01-04 ·Pages 47-9

Tse HF, Kwong YL, Chan JK, Lo G, Ho CL, Lau CP

Abstract

Results of experimental studies have shown that intramyocardial implantation of bone marrow cells induces neovascularisation and improves heart function after myocardial infarction. Our aim was to test this notion in people. We implanted autologous mononuclear bone marrow cells into the ischaemic myocardium of eight patients with severe ischaemic heart disease as guided by electromechanical mapping with a percutaneous catheter procedure. After 3 months of follow-up, there was improvement in symptoms, myocardial perfusion, and function at the ischaemic region on MRI. Future randomised, controlled studies are required to validate this initial encouraging result.

MeSH Terms
Aged Bone Marrow Transplantation/methods Feasibility Studies Female Flow Cytometry Humans Male Middle Aged Myocardial Ischemia/therapy Neovascularization, Physiologic Prospective Studies Tomography, Emission-Computed, Single-Photon Treatment Outcome
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Tse Hung-Fat
Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong, China. hftse@hkucc.hku.hk
Kwong Yok-Lam
Chan John K F
Lo Gladys
Ho Chi-Lai
Lau Chu-Pak
Article Info
Journal
Lancet (London, England)
Abbr.
Lancet
ISSN
0140-6736
Published
2003-01-04
Pages
47-9
Language
English
Region
England
NLM ID
2985213R
Subset
IM
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com